Simvastatin and Dabrafenib: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 4, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Dabrafenib
Simvastatin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on: Dabrafenib (Tafinlar) speeds up an enzyme in your liver called CYP3A4. That same enzyme breaks down simvastatin (Zocor). So when you take both, your body clears the simvastatin faster and less of it stays in your blood.
The concern is that your cholesterol medicine may not work as well as it should, so your LDL (bad cholesterol) might not stay controlled. This isn't about a dangerous buildup, it's about the statin possibly doing less. The good news is your care team can manage this easily by checking your cholesterol levels and adjusting your plan if needed. Please don't stop either medicine, just talk with your pharmacist or doctor.
Mechanism: Dabrafenib is a CYP3A4 inducer; simvastatin is a sensitive CYP3A4 substrate. Co-administration increases simvastatin metabolism, lowering plasma concentrations and AUC, which may reduce lipid-lowering efficacy.
- Direction: Reduced simvastatin exposure (loss of efficacy), not toxicity.
- Magnitude: Dabrafenib reduced midazolam AUC by ~65%; a comparable reduction is plausible for simvastatin.
- Onset: Unspecified (enzyme induction typically develops over days).
- Evidence: Probable.
- Management: Consider an alternative agent, or monitor lipid panel and titrate the statin dose as needed if concurrent use is unavoidable.
What happens
Reduced sensitive CYP3A4 substrate exposure
Interaction Deep Dive
When dabrafenib, which induces CYP3A4, is given together with sensitive CYP3A4 substrates, the plasma levels of those substrates can fall, potentially causing them to lose their effectiveness. In drug interaction studies, the AUC of midazolam (a CYP3A4 substrate) was reduced by 65% by dabrafenib. Since other CYP3A4 substrates are likely to behave in a comparable manner, replace such drugs with alternatives, or, when that cannot be avoided, watch patients for any loss of efficacy of these medications1.
Why it happens (mechanism)
Induction of CYP3A4 substrate metabolism by dabrafenib
How to manage this interaction
Keep taking both medications as prescribed unless your care team tells you otherwise. This interaction is manageable.
- Your team may check your cholesterol (lipid panel) more closely to see if the statin is still working.
- The simvastatin dose may need to be adjusted and individualized by your care team, or they may choose a different cholesterol medicine that isn't affected as much.
- Tell your pharmacist or prescriber that you take both, and mention any changes in your cholesterol results at follow-up visits.
The key point is that reduced statin effect can be tracked with lab work and handled by your care team.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In studies examining drug interactions, giving dabrafenib 150 mg twice daily over 15 days together with a single dose of midazolam (a CYP3A4 substrate) reduced the midazolam AUC by 65% 1.
Common questions
Can I take Simvastatin and Dabrafenib together?
Dabrafenib can make simvastatin work less well by clearing it faster, so your care team may monitor your cholesterol and adjust the dose or switch statins. Keep taking both as prescribed and follow up on your lipid labs. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Simvastatin and Dabrafenib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Simvastatin and Dabrafenib interaction managed?
Keep taking both medications as prescribed unless your care team tells you otherwise. This interaction is manageable. Your team may check your cholesterol (lipid panel) more closely to see if the statin is still working. The simvastatin dose may need to be adjusted and individualized by your care team, or they may choose a different cholesterol medicine that isn't affected as much. Tell your pharm… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Simvastatin or Dabrafenib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: TAFINLAR(R) oral capsules, tablets for suspension, dabrafenib oral capsules, tablets for suspension. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2023. DailyMed
Keep reading about Dabrafenib
Keep reading about Simvastatin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist